Current classification of macular neovascularization in the course of AMD based on the Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

Despite the improvement of diagnostic and therapeutic techniques age-related macular degeneration is still one of the main causes of central vision impairment. Throughout the years, the classification of subretinal neovascularization in the course of age-related macular degeneration has changed due to the advancement of diagnostic and therapeutic techniques. In 2020 an expert panel reached consensus on a new nomenclature for neovascularization in the course of age-related macular degeneration introducing the concept of macular neovascularization, which refers to each neovascularization in macula, regardless of the location.